A R T I C L E S
Sharif et al.
by phosphorylation of the 5′-hydroxyl group of 15N-labeled VIa71-73
with phosphorus pentoxide in phosphoric acid. It was purified with a
cation exchange column. The procedures for obtaining the unlabeled
Schiff bases were described previously.46
5. 15N-Labeled Pyridoxine (PN) (V). A solution containing 1.9 g
(12 mmol) of 15N-labeled 2-methyl-3-hydroxy-4,5-epoxydimethyl-
pyridine (IV) in 12 mL of 48% hydrobromic acid was heated under
reflux for 1 h. Upon cooling in ice water, crystals separated and were
filtered and washed with diethylether. The hydrochloride was prepared
by boiling the hydrobromide for 30 min in 100 mL of water and
removing the bromide ions with freshly prepared silver chloride. The
filtrate was evaporated to dryness. The pyridoxine hydrochloride was
1
. 15N-Labeled d,l-Alanine (2-Aminopropionic acid) (I). Eight
grams (52 mmol) of 2-bromopropionic acid was dissolved in 250 mL
15
74
of water by adding an approximately 20% solution of NH
3
in water.
The product reacted positive to the ninhydrin test for the presence of
amino groups (1% in water, followed by heating). Yield: 3.0 g (64%).
2 2 3
purified by column chromatography (silica, CH Cl /CH OH, 10:1). The
1
15
H NMR (500 MHz, D
2
15
O, room temperature) (ppm/TMS): δ 1.50 (dd,
product was checked by mass spectroscopy, and the N isotopic
3
1
1
3
1
3
1
1
1
J( H, H) ) 7.0 Hz, J( N, H) ) 3.0 Hz, 3H, -CH
3
), 3.8 (q, J( H, H)
7 Hz, 1H, -CH-). C { H} NMR (125 MHz, D O, room
), 50.74 (d, -CH-,
enrichment was estimated as >90%. Yield: 2.1 g (84%). H NMR
1
3
1
2
15
1
)
2
(500 MHz, D
2
O, room temperature) (ppm/TMS): δ 2.65 (d, J( N, H)
), 4.81 (s, 2H, 5′-CH -), 5.01 (s, 2H, 4′-CH -),
8.17 (d, J( N, H) ) 3.2 Hz, 1H, 6-CH). C { H} NMR (125 MHz,
temperature) (ppm/TMS): δ 16.40 (s, -CH
3
) 3.2 Hz, 3H, 2′-CH
3
2
13
2
1
15
13
2
15
1
1
J( N, C) ) 5.6 Hz), 175.95 (s, -COOH).
1
5
D O, room temperature) (ppm/TMS): δ 14.56 (s, 2′-CH ), 57.00 (s,
2
.
N-Labeled Ethyl-N-formyl-d,l-alaninate (II). A mixture of
2
3
1
5
4′-CH -), 58.3 (s, 5′-CH -), 130.00 (d,
1
J(15N,13C) ) 12.7 Hz, C6),
4
g (45 mmol) of N-labeled d,L-alanine (I), 6.3 g (137 mmol) of abs
2
2
1
15
13
formic acid, and 140 mL of abs ethanol was allowed to react in an
autoclave at 220 °C overnight and was then chilled in an ice bath. The
ethanol and water formed in the reaction were distilled off under reduced
pressure. Next, 140 mL of ethanol was added to the residue and
removed under reduced pressure. This treatment was repeated three
times. The residue was distilled in a bulb tube at 80-100 °C and 0.3
136.96 (s, C5), 140.79 (s, C4), 142.95 (d, J( N, C) ) 14.4 Hz, C2),
152.93 (s, C3). These 1 C NMR data are similar to those reported
previously for unlabeled pyridoxine.7
3
5,76
6. 15N-Labeled (Ring and Doubly) N-(Pyridoxylidene)tolylamine
1
5
(VIa,b). For preparation of the ring or doubly N-labeled product,
0.4 g (1.9 mmol) of 15N-labeled pyridoxine hydrochloride (V) in
mbar. The product was stored under inert gas at -23 °C. Yield: 3.3 g
aqueous solution was added to MnO that was freshly prepared from
2
1
(
50%). H NMR (500 MHz, CDCl
3
, room temperature) (ppm/TMS):
0.3 g of potassium permanganate, 0.4 g of sodium bisulfite NaHSO3,
and 1 mL of 50% sulfuric acid in 20 mL of water. The solution was
3
1
1
3
1
1
δ 1.27 (t, J( H, H) ) 7.2 Hz, 3H, -CH
)
2
-CH
), 4.20 (q, J( H, H) ) 7.2 Hz,
), 4.60 (q, J( H, H) ) 7.2 Hz, 1H, -CH-), 6.52 (ddd,
3
), 1.42 (dd, J( H, H)
3
15
1
3
1
1
15
7.2, J( N, H) ) 2.7 Hz, 3H, -CH
3
stirred for 4 h after adding 0.3 g (2.2 mmol) of p-toluidine and/or N-
3
1
1
2
H, -CH
2
-CH
3
labeled p-toluidine (IX). After diluting the solution to 400 mL with
1
15
1
3
1
3
1
1
J( N, H) ) 92.0, J(H, H) ) 7.6, J( H, H) ) 1.6 Hz, 1H, HN), 8.16
water, the pH was adjusted with 1 M NaHCO solution to 7.5. The
3
2
15
1
13
1
(
d, J( N, H) ) 16.1 Hz, 1H, -CHO). C { H} NMR (125 MHz,
CDCl , room temperature) (ppm/TMS): δ 14.24 (s, -CH -CH ), 18.62
), 47.06 (d, J( N, C) ) 11.7 Hz, -CH-), 61.87 (s, -CH -),
60.82 (d, J( N, C) ) 13.37 Hz, -CHO), 172.81 (s, -COOH).
Schiff base that precipitated from solution was filtered and washed
with water. The product was dried under vacuum. By using unlabeled
3
2
3
1
15 13
15
(s, -CH
3
2
p-toluidine, the singly ring N-labeled Schiff base was obtained.
1
15
13
15
1
1
Yield: 0.18 g (37%). VIa ( N-ring-labeled): H NMR (500 MHz,
DMSO-d , room temperature) (ppm/TMS): δ 2.36 (s, 3H, Ar-CH ),
2.43 (d, 3H, J( N, H) ) 2.9 Hz, 2′-CH ), 4.77 (d, 2H, J( H, H) )
-), 5.42 (t, 1H, J( H, H) ) 5.5 Hz, 5′′-OH), 7.30-
1
5
3
.
N-Labeled 5-Ethoxy-4-methyloxazole (III). Freshly prepared
6
3
1
5
2
15
1
3
1
1
(4 g; 27 mmol) N-labeled ethyl-N-formyl-d,l-alaninate (II) was
3
3
1
1
dissolved in 250 mL of dist dichloromethane, and 17 g of P was
O
2 5
5.5 Hz, 5′-CH
7.45 (m, 4H, -C
(s, 1H, H4′), 14.06 (s, 1H, H3′).
2
2
15
1
added slowly. The reaction mixture was heated for 24 h under reflux.
The solution was chilled to 0 °C, and 250 mL of 20% aqueous NaOH
was slowly added. The suspension was extracted four times with
6 4
H -), 7.99 (d, 1H, J( N, H) ) 11.0 Hz, H6), 9.18
. 15N-Labeled (Imino) N-(Pyridoxylidene)tolylamine (VIc). The
imino N-labeled product was prepared as follows. An aqueous solution
7
3
00 mL of dichloromethane and dried over NaHCO
3
; the solvent was
15
removed under reduced pressure. The residue was distilled in a bulb
tube at 39 °C and 25 mbar. The product was stored under inert gas at
of 0.37 g (2.2 mmol) of pyridoxal hydrochloride was added to 0.3 g
15
(
2.2 mmol) of N-labeled p-toluidine (IX). The resulting mixture was
1
-
23 °C. Yield: 2.7 g (78%). H NMR (500 MHz, CDCl
3
, room
3
brought to a pH 7.5 by adding 1 M NaHCO solution. The mixture
was kept on ice for 5 h, after which crystals were filtered off, washed
with cold water and diethylether, and dried under vacuum. Yield:
3
1
1
temperature) (ppm/TMS): δ 1.34 (t, J( H, H) ) 7.1 Hz, 3H, -CH -
2
3
15
1
3
1
1
CH
3
), 2.03 (d, J( N, H) ) 2.3 Hz, 3H, -CH
3
), 4.15 (q, J( H, H) )
), 7.37 (d, J( N, H) ) 12.6 Hz, 1H, -CH).
C { H} NMR (125 MHz, CDCl , room temperature) (ppm/TMS): δ
0.18 (d, J( N, C) ) 6.4 Hz, -CH ), 15.19 (s, -CH -CH ), 70.32
-), 112.5 (d, J( N, C) ) 1.6 Hz, C4), 142.36 (d, J( N, C)
2
15
1
7
.1 Hz, 2H, -CH
2
-CH
3
1
0
(
.32 mg (57%). H NMR (500 MHz, DMSO-d
6
, room temperature)
), 4.77 (d,
-), 5.42 (t, 1H, J( H, H) ) 5.5 Hz,
-), 7.98 (s, 1H, H6), 9.18 (d, 1H,
1
3
1
3
ppm/TMS): δ 2.36 (s, 3H, Ar-CH ), 2.43 (s, 3H, 2′-CH
H, J( H, H) ) 5.5 Hz, 5′-CH
′′-OH), 7.30-7.45 (m, 4H, -C
3
3
2
15
13
1
3
2
3
3
1
1
3
1
1
2
5
2
1
15 13
15
1
15 13
(s, -CH
2
6
H
4
2
13
)
1.2 Hz, C2), 154.56 (d, J( N, C) ) 0.9 Hz, C5).
N-Labeled 2-Methyl-3-hydroxy-4,5-epoxydimethylpyridine
IV). A solution of freshly prepared, 2.5 g (20 mmol) of N-labeled
2
15
1
J( N, H) ) 3.4 Hz, H4′), 14.06 (s, 1H, H3′).
1
5
4
.
. 15N-Labeled 5′-Triisopropylsilyl Ether of N-(Pyridoxylidene)-
8
15
(
15
tolylamine (VII). This synthesis was used to protect the selective N-
5
-ethoxy-4-methyloxazole (III) in a 20-fold molar excess of 2,5-
labeling in the imino or in the ring position, depending on the
dihydrofuran containing 1% trichloroacetic acid was heated in an
autoclave for 5 h at 190 °C. After cooling to room temperature
overnight, the precipitate was washed with diethylether. Excess 2,5-
dihydrofurane was removed under high vacuum, and the product was
15
N-labeling of the starting material. In 2 mL of abs DMF, 140 mg
15
(0.55 mmol) of N-labeled N-(pyridoxylidene)tolylamine was dissolved,
with stirring under an inert gas atmosphere. Then, 94 mg (1.38 mmol)
of imidazole was added. After a few minutes of stirring, 126 mg
purified by column chromatography (silica, CH
2
Cl
OD, room temperature)
ppm/TMS): δ 2.42 (d, J( N, H) ) 3.0 Hz, 3H, -CH ), 5.05 (m,
2
/MeOH, 10:1).
(0.66 mmol) of triisopropylsilyl chloride was added dropwise. The molar
1
Yield: 1.9 g (63%). H NMR (500 MHz, CD
3
ratio of reactant/chlorosilane/imidazole was 1:1.2:2.5. The solution was
stirred under an inert atmosphere for 3 days. The reaction was monitored
by TLC (silica, CH Cl /MeOH 10:0.3). The reaction was stopped by
2 2
3
15
1
(
3
2
15
1
4
H, -CH -), 7.77 (d, J( N, H) ) 9.2 Hz, 1H, CH).
2
dropping the mixture into 25 mL of 1 M sodium hydrogen carbonate
solution. The aqueous phase was extracted two times with 100 mL of
dist hexane. The combined organic phases were dried over NaHCO .
3
(
71) Chang, Y. C.; Graves, D. J. J. Biol. Chem. 1985, 260, 2709-2714.
72) Iwanami, M.; Numata, T.; Murakami, M. Bull. Chem. Soc. Jpn. 1968, 41,
(
1
61-165.
(
73) Muhlradt, P. F.; Morino, Y.; Snell, E. E. J. Med. Chem. 1967, 10, 341-
44.
74) Wehrle, B.; Zimmermann, H.; Limbach, H. H. J. Am. Chem. Soc. 1988,
10, 7014-7024.
3
(
(75) Harruff, R. C.; Jenkins, W. T. Org. Magn. Reson. 1976, 8, 548-557.
(76) Witherup, T. H.; Abbott, E. H. J. Org. Chem. 1975, 40, 2229-2234.
1
4444 J. AM. CHEM. SOC.
9
VOL. 129, NO. 14, 2007